Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Frank Karbe files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert Charles Breedlove - $7K in PHAT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Frank Karbe?
Frank Karbe is a corporate insider of Phathom Pharmaceuticals, Inc. (PHAT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Frank Karbe last file a Form 4?
The most recent primary Form 4 on record is dated 21 May 2026, one of 3 filings going back to 2024.
Has Frank Karbe been buying or selling stock?
Recorded transactions: 1 open-market purchase ($99K) and 0 open-market sales across all tracked filings.
